SEC Form 4 · accession 0001190725-17-000078
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rodney W Lappe
Director
Period of report
Mar 30, 2017
Accepted (ET)
Apr 3, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $5.15 | Mar 30, 2017 | A | 5,000 | A | — | Mar 29, 2027 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.